hrs9950
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 15, 2020 (NCT04464733)
Timeline
Indications
Studied for
Mechanism of action
- Toll-like receptor 8AGONIST
TLR8 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05905458 | Phase 2 | Jul 28, 2023 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| NCT04464733 | Phase 1 | Jul 15, 2020 | Hengrui Therapeutics, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hengrui Therapeutics, Inc. | For profit | 1 | 1 | 1 | 2020 |
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | For profit | 1 | 1 | 1 | 2023 |
2 organizations
Page 1 / 1